These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37242150)

  • 21. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
    Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
    Nephrol Dial Transplant; 2020 Nov; 35(11):1908-1915. PubMed ID: 31361316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Zhou H; Yang M; Jiang Z; Ding J; Di J; Cui L
    Am J Nephrol; 2018; 48(1):46-55. PubMed ID: 30048964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Body Weight Variability with Adverse Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Park SK; Kim YS; Kim YH; Choi KH; Oh KH; Ma SK; Kim SW; On Behalf Of The KoreaN Cohort Study For Outcomes In Patients With Chronic Kidney Disease Know-Ckd Investigators
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with 30-day Major Adverse Cardiovascular Event in Acute Coronary Syndrome Patients with Non-Dialysis Chronic Kidney Disease: A Retrospective Cohort Study.
    Ginanjar E; Hustrini NM; Mansjoer A; Al Hanif MS
    Acta Med Indones; 2023 Jan; 55(1):10-18. PubMed ID: 36999254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Left Ventricular Diastolic Dysfunction With Cardiovascular Outcomes in Patients With Pre-dialysis Chronic Kidney Disease: Findings From KNOW-CKD Study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Oh KH; Choi KH; Oh YK; Ma SK; Kim SW
    Front Cardiovasc Med; 2022; 9():844312. PubMed ID: 35402554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geriatric Nutritional Risk Index Is Associated with Unique Health Conditions and Clinical Outcomes in Chronic Kidney Disease Patients.
    Lin TY; Hung SC
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31739530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study.
    Suh SH; Oh TR; Choi HS; Yang EM; Kim CS; Bae EH; Ma SK; Oh KH; Jung JY; Hyun YY; Kim SW
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
    Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
    Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
    Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
    J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.
    Palau V; Riera M; Duran X; Valdivielso JM; Betriu A; Fernández E; Pascual J; Soler MJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):130-138. PubMed ID: 30102333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study.
    Ishikura K; Uemura O; Hamasaki Y; Ito S; Wada N; Hattori M; Ohashi Y; Tanaka R; Nakanishi K; Kaneko T; Honda M; ;
    Nephrol Dial Transplant; 2014 Apr; 29(4):878-84. PubMed ID: 24516225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary Protein Intake, Protein Energy Wasting, and the Progression of Chronic Kidney Disease: Analysis from the KNOW-CKD Study.
    Lee SW; Kim YS; Kim YH; Chung W; Park SK; Choi KH; Ahn C; Oh KH
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study.
    Schneider MP; Schmid M; Nadal J; Wanner C; Krane V; Floege J; Saritas T; Busch M; Sitter T; Friedrich N; Stockmann H; Meiselbach H; Nauck M; Kronenberg F; Eckardt KU;
    Am J Kidney Dis; 2022 Oct; 80(4):483-494.e1. PubMed ID: 35288215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
    Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
    Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease.
    Tsai YC; Lee CS; Chiu YW; Kuo HT; Lee SC; Hwang SJ; Kuo MC; Chen HC
    PLoS One; 2015; 10(8):e0135181. PubMed ID: 26274392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.